AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Medtronic's Trading Volume Drops 32.13% to $496 Million Ranking 170th in Daily Volume
Generated by AI AgentAinvest Volume Radar
Friday, Jun 20, 2025 7:56 pm ET1min read
On June 20, 2025, Medtronic's trading volume reached $496 million, marking a 32.13% decrease from the previous day. The stock ranked 170th in terms of trading volume for the day. Medtronic's stock price increased by 0.70%.
Medtronic, a global leader in healthcare technology, recently announced that MiniMed will be the name for its planned New Diabetes Company. This strategic move is part of Medtronic's efforts to streamline its operations and focus on its core competencies. The new company will leverage Medtronic's advanced technology and expertise in diabetes management, aiming to provide innovative solutions for individuals with type 2 diabetes.
Medtronic's MiniMed 780G system, which integrates continuous glucose monitoring (CGM) with insulin pumps, remains a strong competitor in the diabetes management market. The system's advanced features and user-friendly design have garnered positive feedback from healthcare professionals and patients alike. This product line is expected to continue driving growth for
, even as the company spins off its diabetes unit.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet